Paul B Manning - Net Worth and Insider Trading
Paul B Manning Net Worth
The estimated net worth of Paul B Manning is at least $705 Million dollars as of 2025-07-24. Paul B Manning is the Director, 10% Owner of Dova Pharmaceuticals Inc and owns about 14,762,242 shares of Dova Pharmaceuticals Inc (DOVA) stock worth over $414 Million. Paul B Manning is the Director of Liquidia Corp and owns about 6,582,192 shares of Liquidia Corp (LQDA) stock worth over $124 Million. Paul B Manning is also the 10% Owner of Taysha Gene Therapies Inc and owns about 25,601,111 shares of Taysha Gene Therapies Inc (TSHA) stock worth over $66 Million. Besides these, Paul B Manning also holds AveXis Inc (AVXS) , Candel Therapeutics Inc (CADL) , Verrica Pharmaceuticals Inc (VRCA) , Acumen Pharmaceuticals Inc (ABOS) . Details can be seen in Paul B Manning's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Paul B Manning has not made any transactions after 2025-05-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Paul B Manning
Paul B Manning Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paul B Manning owns 8 companies in total, including Taysha Gene Therapies Inc (TSHA) , Verrica Pharmaceuticals Inc (VRCA) , and Dova Pharmaceuticals Inc (DOVA) among others .
Click here to see the complete history of Paul B Manning’s form 4 insider trades.
Insider Ownership Summary of Paul B Manning
Ticker | Company | Transaction Date | Type of Owner |
---|---|---|---|
TSHA | Taysha Gene Therapies Inc | 2025-05-30 | director & 10 percent owner |
VRCA | Verrica Pharmaceuticals Inc | 2023-07-24 | director & 10 percent owner |
DOVA | Dova Pharmaceuticals Inc | 2019-11-12 | director & 10 percent owner |
![]() | ![]() | 2018-05-15 | director & other: Former 10% Owner |
![]() | ![]() | 2021-07-06 | 10 percent owner |
![]() | ![]() | 2024-09-12 | director & 10 percent owner |
![]() | ![]() | 2024-12-16 | director |
![]() | ![]() | 2022-10-22 | 10 percent owner |
Paul B Manning Latest Holdings Summary
Paul B Manning currently owns a total of 7 stocks. Among these stocks, Paul B Manning owns 14,762,242 shares of Dova Pharmaceuticals Inc (DOVA) as of August 9, 2019, with a value of $414 Million and a weighting of 58.7%. Paul B Manning owns 6,582,192 shares of Liquidia Corp (LQDA) as of September 12, 2024, with a value of $124 Million and a weighting of 17.52%. Paul B Manning also owns 25,601,111 shares of Taysha Gene Therapies Inc (TSHA) as of May 30, 2025, with a value of $66 Million and a weighting of 9.4%. The other 4 stocks AveXis Inc (AVXS) , Candel Therapeutics Inc (CADL) , Verrica Pharmaceuticals Inc (VRCA) , Acumen Pharmaceuticals Inc (ABOS) have a combined weighting of 14.37% among all his current holdings.
Latest Holdings of Paul B Manning
Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
DOVA | Dova Pharmaceuticals Inc | 2019-08-09 | 14,762,242 | 28.04 | 413,933,266 |
LQDA | Liquidia Corp | 2024-09-12 | 6,582,192 | 18.77 | 123,547,744 |
TSHA | Taysha Gene Therapies Inc | 2025-05-30 | 25,601,111 | 2.59 | 66,306,877 |
AVXS | AveXis Inc | 2016-09-13 | 252,939 | 217.83 | 55,097,702 |
CADL | Candel Therapeutics Inc | 2024-12-16 | 4,127,158 | 7.00 | 28,890,106 |
VRCA | Verrica Pharmaceuticals Inc | 2023-07-24 | 15,589,481 | 0.70 | 10,912,637 |
ABOS | Acumen Pharmaceuticals Inc | 2021-07-06 | 4,010,678 | 1.61 | 6,457,192 |
Holding Weightings of Paul B Manning
Paul B Manning Form 4 Trading Tracker
According to the SEC Form 4 filings, Paul B Manning has made a total of 0 transactions in Dova Pharmaceuticals Inc (DOVA) over the past 5 years. The most-recent trade in Dova Pharmaceuticals Inc is the acquisition of 28,062 shares on August 9, 2019, which cost Paul B Manning around $445,344.
According to the SEC Form 4 filings, Paul B Manning has made a total of 4 transactions in Liquidia Corp (LQDA) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Liquidia Corp is the acquisition of 337,078 shares on September 12, 2024, which cost Paul B Manning around $3 Million.
According to the SEC Form 4 filings, Paul B Manning has made a total of 8 transactions in Taysha Gene Therapies Inc (TSHA) over the past 5 years, including 8 buys and 0 sells. The most-recent trade in Taysha Gene Therapies Inc is the acquisition of 750,000 shares on May 30, 2025, which cost Paul B Manning around $2 Million.
More details on Paul B Manning's insider transactions can be found in the Insider Trading History of Paul B Manning table.Insider Trading History of Paul B Manning
- 1
Paul B Manning Trading Performance
GuruFocus tracks the stock performance after each of Paul B Manning's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Paul B Manning is 5.5%. GuruFocus also compares Paul B Manning's trading performance to market benchmark return within the same time period. The performance of stocks bought by Paul B Manning within 3 months outperforms 13 times out of 35 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Paul B Manning's insider trading performs compared to the benchmark.
Performance of Paul B Manning
Paul B Manning Ownership Network
Ownership Network List of Paul B Manning
Ownership Network Relation of Paul B Manning

Paul B Manning Owned Company Details
What does Taysha Gene Therapies Inc do?
Who are the key executives at Taysha Gene Therapies Inc?
Paul B Manning is the director & 10 percent owner of Taysha Gene Therapies Inc. Other key executives at Taysha Gene Therapies Inc include Chief Financial Officer Kamran Alam , 10 percent owner Session R.a. Ii , and 10 percent owner Astellas Pharma Inc. .
Taysha Gene Therapies Inc (TSHA) Insider Trades Summary
Over the past 18 months, Paul B Manning made 2 insider transaction in Taysha Gene Therapies Inc (TSHA) with a net purchase of 2,083,333.
In summary, during the past 3 months, insiders sold 0 shares of Taysha Gene Therapies Inc (TSHA) in total and bought 750,000 shares, with a net purchase of 750,000 shares. During the past 18 months, 0 shares of Taysha Gene Therapies Inc (TSHA) were sold and 2,083,333 shares were bought by its insiders, resulting in a net purchase of 2,083,333 shares.
Taysha Gene Therapies Inc (TSHA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Taysha Gene Therapies Inc Insider Transactions
Paul B Manning Mailing Address
Above is the net worth, insider trading, and ownership report for Paul B Manning. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Paul B Manning's mailing address is: Charlottesville Va 22902.